These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11363651)

  • 1. Delavirdine expanded access program.
    BETA; 1996 Jun; ():7. PubMed ID: 11363651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delavirdine available on expanded access.
    AIDS Treat News; 1996 Apr; (no 245):3. PubMed ID: 11363622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded access for delavirdine.
    Posit Aware; 1996; 7(3):5-6. PubMed ID: 11363426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral load: new confirmation from major delavirdine studies.
    James JS
    AIDS Treat News; 1996 Jan; (no 239):2-3. PubMed ID: 11363084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delavirdine/protease inhibitor interactions.
    Gilden D
    GMHC Treat Issues; 1996 Sep; 10(9):11-2. PubMed ID: 11363839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delavirdine gets the green light.
    Vazquez E
    Posit Aware; 1997; 8(3):18-9. PubMed ID: 11364419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delavirdine gains approval as second NNRTI for anti-HIV combination regimens.
    Crit Path AIDS Proj; 1997; (No 32):29-30. PubMed ID: 11364439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delavirdine (Rescriptor) approved.
    James JS
    AIDS Treat News; 1997 Apr; (No 269):1-3. PubMed ID: 11364252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delavirdine data: skewed or skewered?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Feb; 3(2):42-6. PubMed ID: 11364099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-nucleoside reverse transcriptase inhibitors.
    Bowers M
    BETA; 1996 Jun; ():19-22. PubMed ID: 11363645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine and delavirdine plus protease inhibitors.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
    Mascolini M
    AIDS Treat News; 1996 Dec; (No 260):3-5. PubMed ID: 11364022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delavirdine gets FDA approval. Food and Drug Administration.
    AIDS Alert; 1997 Jun; 12(6):70. PubMed ID: 11364363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new class of anti-HIV drugs.
    Treat Rev; 1996 Aug; (No 22):8-9. PubMed ID: 11363816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delavirdine levels in women.
    Vazquez E
    Posit Aware; 1997; 8(4):14. PubMed ID: 11364481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New combination medications].
    Agosto M
    Sidahora; 1997; ():43-6. PubMed ID: 11364501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral roundup.
    Smart T; Torres G
    GMHC Treat Issues; 1996 Aug; 10(8):6-7. PubMed ID: 11363720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delavirdine dilemma at the FDA. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1996 Dec; 10(12):4-5. PubMed ID: 11364017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor.
    Freimuth WW
    Adv Exp Med Biol; 1996; 394():279-89. PubMed ID: 8815692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three drugs now in expanded access.
    Gilden D
    GMHC Treat Issues; 1997 Oct; 11(10):12. PubMed ID: 11364820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.